| 000 | 01483 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513100943.0 | ||
| 264 | 0 | _c19961105 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLewis, T A | |
| 245 | 0 | 0 |
_aGallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cSep 1996 |
||
| 300 |
_a1244-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigen-Presenting Cells _xdrug effects |
| 650 | 0 | 4 |
_aArsenicals _xpharmacology |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aGallium _xpharmacology |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class II _xmetabolism |
| 650 | 0 | 4 | _aHybridomas |
| 650 | 0 | 4 |
_aInterleukin-2 _xmetabolism |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C3H |
| 650 | 0 | 4 | _aMice, Inbred DBA |
| 650 | 0 | 4 |
_aPeptides _ximmunology |
| 650 | 0 | 4 |
_aSpleen _xcytology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Helper-Inducer _ximmunology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aMunson, A E | |
| 700 | 1 | _aMcCoy, K L | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 278 _gno. 3 _gp. 1244-51 |
|
| 999 |
_c8813766 _d8813766 |
||